Correction: Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter clinical study.

WakasakiI, Takahiro; Manako, Tomomi; YasumatsuI, Ryuji; Hara, Hirotaka; Toh, Satoshi; Masuda, Muneyuki; YamauchiID, Moriyasu; Kuratomi, Yuichiro; Nishimura, Emi; Takeuchi, Toranoshin; Matsuo, Mioko; Jiromaru, Rina; Hashimoto, Kazuki; Komune, Noritaka; Nakagawa, Takashi

WakasakiI, Takahiro; Manako, Tomomi; YasumatsuI, Ryuji; Hara, Hirotaka; Toh, Satoshi; Masuda, Muneyuki; YamauchiID, Moriyasu; Kuratomi, Yuichiro; Nishimura, Emi; Takeuchi, Toranoshin; Matsuo, Mioko; Jiromaru, Rina; Hashimoto, Kazuki; Komune, Noritaka; Nakagawa, Takashi.

PLoS One ; 19(5): e0303720, 2024.

Article em En | MEDLINE | ID: mdl-38722895

ABSTRACT

ABSTRACT

[This corrects the article DOI 10.1371/journal.pone.0271907.].

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: PLoS ONE (Online) / PLoS One / PLos ONE Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google